Merck is set to acquire Terns Pharmaceuticals in a $6.7 billion deal aimed at expanding its oncology pipeline, including…
Articles by Michela Luciano, PhD
Myosin Therapeutics has been awarded $2 million in funding to support a Phase 1/2 clinical trial testing its lead…
Overt Bio said it established a clinical advisory board to support the development of OVT-101, its lead investigational CAR…
A long-lasting gel used to help protect the bowel during radiation therapy for prostate cancer may be successfully used in…
Olverembatinib (HQP1351), used in combination with low-intensity chemotherapy, has shown encouraging therapeutic potential — along with a favorable safety profile…
Komzifti (ziftomenib), a once-daily oral therapy approved for certain people with acute myeloid leukemia (AML), is now included in the…
Women prescribed antipsychotics that raise the levels of prolactin, a hormone that stimulates milk production and regulates reproductive hormones,…
A new blood test capable of detecting multiple cancers at earlier, more treatable stages is now available in the U.S.
Linvoseltamab, now branded as Lynozyfic, has received accelerated approval from the U.S. Food and Drug Administration (FDA) for treating adults…
The first patient has been dosed in a Phase 1 clinical trial evaluating the safety and early efficacy of STX-0712…